Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: Cannabis

AXIM IBS Treatment Options and Market Growth in 2017 and Beyond

AXIM

Irritable bowel syndrome is a chronic condition characterized by discomfort and pain in the abdominal region. Sufferers also experience symptoms such as diarrhea, constipation and gas, and it is believed that the condition is adversely affected by anxiety. Anywhere between 25 and 45 million people are affected by IBS in the United States alone, and 2 out of 3 IBS patients are women. The unfortunate reality for IBS sufferers is that there are few effective long-term treatments that manage symptoms without the risk of side effects. As a result, the IBS market presents plenty of opportunities for alternative treatment methods to make a positive impact on patients worldwide.

Medical Marijuana Products

Pharmaceutical industry experts predict that the market for cannabis products could reach 10 percent of the specialty market by the year 2020, with a market value of $20 billion. With a variety of cannabinoids to test and incorporate …

Continue Reading

Posted in Articles| Tagged , , , , |

MJNA Starts Where it Left off in 2016 with Big International Growth

HempMeds

To say that Medical Marijuana, Inc. made headlines in 2016 would be an understatement. In reality, the company known for its CBD hemp oil products took the medical marijuana market by storm with product availability in all 50 states. Since its launch in 2012, MJNA‘s subsidiary company, HempMeds, has made it easier for patients around the country to access relief for a variety of medical issues without the debilitating side effects that often accompany traditional treatment methods. In 2015, the market for hemp products in the United States climbed to $573 million, and that figure is expected to increase dramatically over the next several years. According to estimates from the Hemp Business Journal, the market for CBD is expected to reach $2.1 billion by 2020.

MJNA’s Subsidiary Companies

MJNA‘s subsidiaries include HempMeds, Kannaway, HempMeds MX and HempMeds Brasil. Each of these subsidiaries serves a unique segment of the cannabis …

Continue Reading

Posted in Articles| Tagged , , , , |

Rocky Mountain High Brands to Attend 2017 CannaCon Convention – The World’s Largest Cannabis Convention

DALLAS, Feb. 02, 2017 (GLOBE NEWSWIRE) — Rocky Mountain High Brands, Inc. (OTCQB:RMHB), a fully reporting consumer goods company specializing in hemp-infused food and beverage products and a naturally high alkaline water announced today that representatives of the Company will be in attendance at this year’s Seattle CannaCon Convention.

“Where the Cannabis Industry Does Business”

CannaCon Seattle is a three-day expo (February 16th-18th) that brings together buyers, exhibitors and consumers of the medical and recreational cannabis industry. CannaCon is the world’s largest Cannabis business marketplace boasting over 300 vendors and 10,000+ attendees per show. CannaCon is the number one marketplace for producers, processors and retailers.

Rocky Mountain High Brands representatives will be located in Booth 215 and will be offering free samples of all the delicious flavors of hemp-infused beverages and discounted cases of product from our Washington State distributor, Rocky Mountain High Society. Rocky Mountain High Brands National Sales …

Continue Reading

Posted in Client News| Tagged , |

MJTV Engages Dr. Gregory Smith As Chief Medical Advisor

WHIPPANY, NJ–(Marketwired – Jan 25, 2017) – Michael James Enterprises, Inc. (OTCQB: MJTV) is extremely pleased to bring on Gregory Smith, M.D. as Chief Medical Advisor to consult with MJTV on the Voluptas Project as well the different Neuroceuticals the Company has under development.

Dr. Smith earned his medical degree from Rush Medical School in Chicago as well as his Master of Public Health from Harvard University. He completed residency training in Preventive Medicine at Walter Reed Army Medical Center. Since leaving the US Army with the rank of Major, Doctor Smith has been in primary Practice care in California, Georgia and Florida for the past 25 plus years.

Doctor Smith trained on the use of cannabinoid pharmaceuticals in California in 2000, and has consulted with several biosynthetic cannabinoid manufacturers over past four years. Dr. Smith wrote “Medical Cannabis: Basic Science and Clinical Applications,” in 2016 published by Aylesbury Press. …

Continue Reading

Posted in Client News| Tagged , , , |

Meet the Newest Cannabis Industry Experts to Join the AXIM Advisory Board

AXIM Biotechnologies

Success begins with strategic partnership, and AXIM Biotechnologies, Inc. (OTCQB: AXIM) is poised for continued success thanks to the decision to partner with several cannabis industry experts. These experts will join the AXIM Advisory Board to provide their perspectives on company progress and future decisions. The AXIM Advisory Board is now proud to include Dr. Ilya Reznik, Professor Renger Witkamp, and Professor John Zajicek.

The AXIM Advisory Board

The AXIM Advisory Board is a team comprised of some of the brightest minds in the industry with members from all over the world. These experts bring their years of industry knowledge and experience to the table to help the company improve on its current successes and lay the foundations for an even more promising future. A strong Board is the key to making informed decisions in a rapidly changing market. From advisement on product pipeline innovations and technological advances to …

Continue Reading

Posted in Articles| Tagged , , , |

AXIM is Setting the Pace in Brave New Markets

AXIM Biotechnologies

AXIM Biotech has recently made headlines with the filing of an IP application for a unique method to extract THC from cannabis. The most unique aspect of this proprietary extraction technique is that it is capable of extracting 95 percent of pure THC content from cannabis. This patent will allow AXIM to make revolutionary gains in medical marijuana research. Previously, it has been difficult for scientists to conduct research on THC as it has not been extracted as a stand-alone compound. AXIM‘s new extraction technique will allow the company’s research and development team to gain greater control during studies that test its effectiveness under different concentrations and conditions.

About THC Extraction

The IP application, filed with the World Intellectual Property Organization, is designed specifically to extract tetrahydrocannabinol acid from cannabis. This makes it possible to create formulations that are more highly concentrated than those created with traditional extraction methods. …

Continue Reading

Posted in Articles| Tagged , , |